{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"73"},{"groupId":"OG001","value":"80"},{"groupId":"OG002","value":"73"}]}],"title":"Haematocrit (<=0.37 ratio)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"32"},{"groupId":"OG001","value":"45"},{"groupId":"OG002","value":"38"}]}],"title":"Haemoglobin (<=115 g/L)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"41"},{"groupId":"OG002","value":"50"}]}],"title":"Serum Urea Nitrogen (>=10.7 mmol/L)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"65"},{"groupId":"OG001","value":"64"},{"groupId":"OG002","value":"63"}]}],"title":"Urine Protein (>=2 units from baseline)"},{"categories":[{"measurements":[{"groupId":"OG000","value":"96"},{"groupId":"OG001","value":"105"},{"groupId":"OG002","value":"107"}]}],"title":"Urine Bacteria (0 at baseline and >0 on treatment)"}],"denoms":[{"counts":[{"groupId":"OG000","value":"202"},{"groupId":"OG001","value":"207"},{"groupId":"OG002","value":"201"}],"units":"Participants"}],"description":"Criteria for lab values changes from baseline to the end of the study considered markedly abnormal were set for each lab test. If 20% of patients reached that value, the results were reported.","groups":[{"description":"Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 160 mg SC (by injection under the skin) given every 28 days.","id":"OG000","title":"Degarelix 240/160 mg"},{"description":"Initial dose of 240 mg SC (by injection under the skin) on day 0. Maintenance dose of 80 mg SC (by injection under the skin) given every 28 days.","id":"OG001","title":"Degarelix 240/80 mg"},{"description":"Lupron Depot 7.5 mg IM (in the muscle) every 28 days starting at day 0.","id":"OG002","title":"Leuprolide 7.5 mg"}],"paramType":"NUMBER","populationDescription":"ITT population","reportingStatus":"POSTED","timeFrame":"Baseline to Day 364","title":"Participants With Markedly Abnormal Change in Laboratory Variables (>=20 Percent of Patients)","type":"SECONDARY","unitOfMeasure":"participants"}